Shinome Brief

Wednesday 9 September 2026

Private edition · 11 min read

Five fitness feeds timed out at collection (Stronger by Science, ScienceDaily Fitness, Athletech week, Club Solutions, one PubMed nutrition query), so the fitness slate leans on PubMed plus the Athletech quarter feed. Two J Strength Cond Res papers indexed this week carry a December 2025 print date, stated in each summary.

AI & Tech

6 stories

The lead

OpenAI claims a Navier-Stokes blow-up proof, and a credit fight lands on top of it

The proof covers the forced version of the equations, not the unforced version the Clay Institute prize actually specifies, and Clay has not ruled. Terence Tao called the approach remarkable without endorsing the claim, and warned that labs able to throw compute at a rumour change what researchers are willing to share early.

OpenAI says an internal model more capable than GPT-6 Astra produced a proof that 3D Navier-Stokes can blow up in finite time. NYU mathematician Tristan Buckmaster says OpenAI knew of his parallel work, took the approach, and pressed him to drop co-author Levent Alpoege because Alpoege works at Anthropic.

Axios

CONVOThis is the story senior people will raise this week, so carry the two-part version: the capability number is real and the governance around it is not settled. The forced-versus-unforced caveat is what separates you from someone repeating a headline.

  1. 1

    An Anthropic pretraining researcher resigned publicly, and the alignment lead backed him

    Jacob Coxon, 27, quit Anthropic after three years of pretraining work at OpenAI and Anthropic, saying neither firm is acting responsibly and that an uncontrollable state could arrive around the end of 2027. Evan Hubinger, who leads alignment science at Anthropic, endorsed the claim under his own name and said the company has no plan for that scenario.

    The Next Web

    CONVOKeep this next to the OpenAI proof story: one is a capability jump, one is an insider saying the safety side has no plan. Naming both in the same breath reads as judgement rather than doom talk.

  2. 2

    Meta launches Muse, a personal agent that runs tasks inside its own secure VM

    Muse launched 8 September in the US for over-18s, with a free tier plus 20 dollar and 100 dollar monthly plans. It runs on a dedicated secure virtual machine with its own browser and is pitched at multi-step errands: booking, shopping, scheduling, filling in forms.

    Meta Newsroom

    JOBForm filling is the exact cost centre in your application pipeline. Watch whether Muse or the Codex desktop route handles a SuccessFactors form end to end before you pay for either.

  3. 3

    Anthropic kept its latest model away from the UK AI Security Institute

    Anthropic excluded the UK government testing agency from pre-release access to its newest model. Officials in London read it as the start of a protectionist turn among the large labs.

    Financial Times

    CONVOUseful in any compliance or risk conversation: voluntary safety testing only works while the labs volunteer, which is the argument for statutory bars rather than frameworks.

  4. 4

    Anthropic power users expand a class action over what the top subscription tier delivered

    An expanded class action claims Anthropic misled heavy users into believing the top-priced plan would give them materially more usage than it did. Anthropic has said publicly that power users are central to its business and has cut off other applications to protect them.

    The Verge

    JOBYou run a paid Claude plan as core infrastructure. Track the docket for what it says about usage caps, because a quota change hits your career-ops and Shinome builds directly.

  5. 5

    Qwen3.8 27B quantization benchmarks: 4-bit holds, 1-bit collapses

    Community benchmarks of the new Qwen3.8 27B release show 4-bit quantization holding quality while 1-bit falls apart, alongside a 1M context Flash-Next variant landing in MLX and llama.cpp.

    Quesma

    JOBFor the Mercor and AI-training lane, 4-bit on local hardware is the cheap way to have a private model you can talk about having actually run. Skip the 1-bit experiments.

Finance & Markets

7 stories

The lead

Pierre Mirabaud convicted of bribery and money laundering, two years suspended

This is the second Swiss retrocession case in a week, after the 16 million franc Geneva prosecution this brief ran on 3 September. Mirabaud asked to be tried under the simplified procedure, which is why the verdict arrived without a full trial.

The Federal Criminal Court convicted the former president of the Swiss Bankers Association of bribing a foreign public official and money laundering, and handed down two years suspended. Roughly 300 transfers moved the equivalent of 82 million francs to a senior Kuwaiti official between 2000 and 2012, and in return the PIFSS pension fund placed 595 million dollars with Banque Mirabaud.

Le Temps

JOBThis is your best live example for interim KYC and compliance interviews in Geneva and Vaud: a named case, a dated conduct window, and a clear failure mode in correspondent and public-fund relationships. Have the 82 million and 595 million figures ready.

  1. 1

    Brent near 100 dollars after US forces destroy five Iranian tankers

    Brent rose 1.55 percent to 99.44 dollars and WTI 1.75 percent to 94.66 dollars after Centcom said US forces destroyed five Iranian crude tankers in response to an attempted attack on a US warship. Oil is up more than 8 percent in September, and Goldman lifted its December 2026 Brent forecast by 5 dollars to 85 while warning Brent could exceed 120 in 2027 if Gulf output stays 4 million barrels a day below prewar levels.

    CNBC

    CONVOThe talking line has moved from shipping risk to the US sinking Iranian export capacity. Use the Goldman split, 85 for December against a 120 tail, when someone asks whether this is priced in.

  2. 2

    US hyperscaler bonds now make up over a quarter of Swiss franc corporate issuance

    Bonds from Alphabet, Amazon and similar issuers account for more than a quarter of Swiss franc corporate issuance this year, as AI capital spending reaches for the cheapest funding currency available.

    Financial Times

    CONVOThis is the sharpest Swiss AI angle you can bring to a Geneva or Zurich interview: the AI build is being financed in francs, which puts it inside the local credit book rather than out in Silicon Valley.

  3. 3

    Novartis falls about 9 percent after a second clinical failure in days

    The Basel group said on Tuesday that a neuromuscular disease candidate missed its endpoints, the second failure inside a few days, and the stock fell close to 9 percent on the Swiss exchange.

    Le Temps

    CONVOSwiss pharma is the sector you get asked about by default. The usable read is pipeline concentration risk, not one bad trial, and it pairs with the generic drug tariff threat also live this week.

  4. 4

    Swiss pension funds are up 5 percent this year and less liquid than they look

    Swiss occupational pension institutions posted a 5 percent return to end-August after a strong 2025. A study warns that the rising share of illiquid holdings narrows their room to move if markets turn.

    Le Temps

    CONVOGood second question material for any Swiss institutional or wealth role: strong headline return, thinner ability to rebalance under stress. It shows you read past the performance line.

  5. 5

    La Poste plans up to 110 job cuts by the end of 2027

    The Swiss postal group announced a cost reduction programme running to end-2027 that could mean up to 110 redundancies, citing falling letter volumes and digital shift.

    Le Temps

    JOBRestructurings put finance and controlling contractors into the market. Flag La Poste to your interim agencies now, since programme work is usually staffed before the cuts land.

  6. 6

    Belgian wealth manager Delen sets up in Zurich and wants Swiss acquisitions

    Delen, the Belgian wealth management specialist, has opened in Zurich and plans to grow partly by buying independent asset managers, in a market where recent deals show heavy competition for those targets.

    Le Temps

    JOBA new entrant building a Swiss book needs integration and deal support before it needs headcount elsewhere. Worth a direct approach on the strength of your one closed transaction.

Fitness & Performance

5 stories
Last 7 daysThe week's research went after the execution variables inside the session and found them small. Rep tempo made no meaningful difference to hypertrophy across 14 controlled studies, a fixed blood flow restriction protocol produced anywhere from 4 to 47 extra reps depending on the person, and matching calories made moderate and heavy cycling equal on fitness. The money moved instead: Hyrox sold at about 700 million dollars.
This quarterFor ninety days the quarter bucket ranked add-ons and found small effects: whole body vibration and blood flow restriction on 29 June, creatine on 6 July, anti-obesity drugs for maintenance on 9 July, photobiomodulation on 20 July, keto at matched energy on 13 August. Late August turned the briefs onto the instruments, with smartwatch calorie error on 2 September and doubly labelled water on 4 September, then proxy versus outcome on 5 September, the HMB ceiling on 7 September and the bariatric surgery ceiling on 8 September. Today moves the test inside the repetition itself. After ruling out the add-on and then the add-on to a stronger intervention, tempo joins the list of things that do not carry the result, which leaves load, volume and turning up.

The lead

Across 14 controlled studies, how fast you lift the weight barely changed hypertrophy

Subgroups by eccentric versus concentric, upper versus lower body and training to failure all produced trivial to small effects. The paper carries a December 2025 print date in J Strength Cond Res and was indexed for MEDLINE this week.

A Bayesian meta-analysis of 14 studies that held every other training variable constant compared slower reps (about 3.5 seconds) against faster ones (about 1 second). Within-group effects were similar, 0.43 for faster and 0.34 for slower, and the pairwise difference trivially favoured faster at 0.09 with a credible interval crossing zero, with a 0.450 probability the difference was even small.

J Strength Cond Res

supportssimple-systemA prescription variable that costs attention and buys nothing measurable is the clearest case for dropping it.

SHINOMEStop coaching tempo counts with Shinome clients unless a client needs them for control or joint comfort. It is one more thing to remember for no measurable return, which is exactly the decision load you are trying to remove.

  1. 1

    A fixed blood flow restriction protocol gave 20 people wildly different amounts of work

    Twenty recreationally active adults ran the standard 30, 15, 15, 15 low-load blood flow restriction leg press. On the final set they completed 19 plus or minus 12 extra reps beyond the prescribed 15, range 4 to 47, with muscular endurance capacity and pain modulation explaining 56 percent of that spread, and they underestimated reps in reserve by 12 plus or minus 11. Same December 2025 print issue, indexed this week.

    J Strength Cond Res

    sharpenssimple-systemA simple fixed protocol is only simple on paper if the stimulus it delivers varies four to tenfold between people.

    SHINOMEIf you ever put blood flow restriction into a Shinome plan, do not treat the standard rep scheme as a dose. Two clients on the same protocol are not doing the same work, and their own reps-in-reserve estimate will not tell you.

  2. 2

    With calories matched, moderate and heavy cycling improved fitness equally and moved no cytokines

    In 56 healthy young adults randomised to six weeks of thrice-weekly moderate or heavy continuous cycling matched for energy expenditure, or no exercise, VO2peak and power at lactate threshold rose with training (p below 0.002) with no significant difference between intensities. Fasting IL-6, IL-10 and TNF-alpha did not change in any group. Epub 16 August 2026.

    J Sci Med Sport

    supportssimple-systemHarder was not better once the energy cost was matched, so intensity can be chosen for adherence.

    SHINOMEFor clients who dread intervals, this is the trial to lean on: at equal energy cost the easier version bought the same fitness. Say what it measured and stop there, because the inflammation markers did not move either way.

  3. 3

    Sixteen trials say resistance training raises strength in people with Down syndrome, with no serious harm

    A meta-analysis of 16 randomised trials found resistance training increased strength (SMD 1.88, 95 percent CI 1.26 to 2.51, I2 72 percent) and improved physical function (SMD -0.58, CI -1.06 to -0.11) in people with Down syndrome, with no serious adverse effects and no clear effect on anthropometric or cardiorespiratory measures.

    J Appl Res Intellect Disabil

    supportsmuscle-is-capitalStrength responds in a population usually excluded from training trials, while the scale does not.

    SHINOMEKeep this on file for the day a parent asks whether strength work is safe for a child or adult with a disability. The honest answer is that strength and function moved and body composition did not.

  4. 4

    Hyrox sold to an L Catterton-led group at a valuation around 700 million dollars

    A consortium led by L Catterton, LVMH's private equity arm, with Jeffrey Katzenberg's WndrCo, took a majority stake in the fitness racing brand as Infront Sports exits. Co-founders Christian Toetzke and Moritz Fuerste hold 51 percent, and reporting puts the valuation near 700 million dollars.

    Athletech News

    SHINOMEFitness racing is now a private equity asset class, which tells you where paying clients are heading. A Shinome offer built around preparing people for a race date sells against a calendar rather than against motivation.